Atezolizumab Combinations With Chemotherapy for Anaplastic and Poorly Differentiated Thyroid Carcinomas
Phase of Trial: Phase II
Latest Information Update: 08 Oct 2017
At a glance
- Drugs Atezolizumab (Primary) ; Bevacizumab; Cobimetinib; Paclitaxel; Vemurafenib
- Indications Thyroid cancer
- Focus Therapeutic Use
- 04 Aug 2017 Planned End Date changed from 1 Sep 2023 to 1 Jul 2023.
- 04 Aug 2017 Planned primary completion date changed from 1 Sep 2023 to 1 Jul 2023.
- 04 Aug 2017 Status changed from not yet recruiting to recruiting.